Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Martínez Poveda, Beatriz ^a   Verotta, Luisella ^b   Bombardelli, Ezio ^c   Quesada, Ana R ^a,d   Medina, Miguel Ángel ^a,d  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b UNIVERSITY OF MILAN   (Italy)

^c INDENA S P A   (Italy)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; HYPERFORIN; MATRIGEL; OCTAHYDROHYPERFORIN; PERFORIN; TETRAHYDROHYPERFORIN; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR; BICYCLO COMPOUND; CARBON; DRUG DERIVATIVE; OXYGEN; PHLOROGLUCINOL; TERPENE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL SPECIFICITY; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; ENDOTHELIUM CELL; EXPERIMENTAL STUDY; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; THERAPY EFFECT; ZYMOGRAPHY; ANIMAL; CATTLE; CELL STRAIN 3T3; CHEMISTRY; CYTOLOGY; HUMAN; IC 50; NEOVASCULARIZATION (PATHOLOGY);

ANGIOGENESIS INHIBITORS; ANIMALS; BICYCLO COMPOUNDS; CARBON; CATTLE; ENDOTHELIAL CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MICE; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; OXYGEN; PHLOROGLUCINOL; TERPENES;

EID: 77949686887     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009558     Document Type: Article

References (27)

1. Di Carlo G, Borrelli F, Ernst E, Izzo AA (2001) St John's wort: Prozac from the plant kingdom. Trends Pharmacol Sci 22: 292-297.
2. Bilia AR, Gallori S, Vincieri FF (2002) St. John's wort and depression: efficacy, safety and tolerability-an update. Life Sci 70: 3077-3096.
3. Mennini T, Gobbi M (2004) The antidepressant mechanism of Hypericum perforatum. Life Sci 75: 1021-1027.
4. Verotta L (2003) Hypericum perforatum, a source of neuroactive lead structures. Curr Top Med Chem 3: 187-201.
5. Verotta L (2003) Are acylphloroglucinols lead structures for the treatment of neurodegenerative diseases? Phytochem Rev 1: 389-407.
6. Dona M, Dell'Aica I, Pezzato E, Sartor L, Calabrese F, et al. (2004) Hyperforin inhibits cancer invasion and metastasis. Cancer Res 64: 6225-6232.
7. Medina MA, Martínez-Poveda B, Amores-Sánchez MI, Quesada AR (2006) Hyperforin: more than an antidepressant bioactive compound? Life Sci 79: 105-111.
8. Cabrelle A, Dell'Aica I, Melchiori L, Carraro S, Brunetta E, et al. (2008) Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease. J Leukoc Biol 83: 212-219.
9. Martínez-Poveda B, Quesada AR, Medina MA (2005) Hyperforin, a bio-active compound of St. John's wort, is a new inhibitor of angiogenesis targeting several key steps of the process. International Journal of Cancer 117.
10. Schempp CM, Kiss J, Kirkin V, Averbeck M, Simon-Haarhaus B, et al. (2005) Hyperforin acts as an angiogenesis inhibitor. Planta Med 71: 999-1004.
11. Dell'Aica I, Niero R, Piazza F, Cabrelle A, Sartor L, et al. (2007) Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis. J Pharmacol Exp Ther 321: 492-500.
12. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
13. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31.
14. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438: 932-936.
15. Quesada AR, Muñoz-Chápuli R, Medina MA (2006) Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev 26: 483-530.
16. Rothley M, Schmid A, Thiele W, Schacht V, Plaumann D, et al. (2009) Hyperforin and aristoforin inhibit lymphatic endothelial cell proliferation in vitro and suppress tumor-induced lymphangiogenesis in vivo. Int J Cancer 125: 34-42.
17. Verotta L, Appendino G, Jakupovic J, Bombardelli E (2000) Hyperforin analogues from St. John's wort (Hypericum perforatum). J Nat Prod 63: 412-415.
18. Verotta L, Lovaglio E, Sterner O, Appendino G, Bombardelli E (2004) Modulation of chemoselectivity by protein additives. Remarkable effects in the oxidation of hyperforin. J Org Chem 69: 7869-7874.
19. Verotta L, Appendino G, Belloro E, Jakupovic J, Bombardelli E (1999) Furohyperforin, a prenylated phloroglucinol from st. John's wort (Hypericum-perforatum). J Nat Prod 62: 770-772.
20. Verotta L, Appendino G, Belloro E, Bianchi F, Sterner O, et al. (2002) Synthesis and biological evaluation of hyperforin analogues. Part I. Modification of the enolized cyclohexanedione moiety. J Nat Prod 65: 433-438.
21. Wolfender JL, Verotta L, Belvisi L, Fuzzati N, Hostettmann K (2003) Structural investigations of isomeric oxidised forms of hyperforin by HPLC-NMR and HPLC-MSn. Phytochem Anal 14: 290-297.
22. Verotta L, Appendino G, Bombardelli E, Brun R (2007) In vitro antimalarial activity of hyperforin, a prenylated acylphloroglucinol. A structure-activity study. Bioorg Med Chem Lett 17: 1544-1548.
23. Feisst C, Albert D, Verotta L, Werz O (2005) Evaluation of hyperforin analogues for inhibition of 5-lipoxygenase. Med Chem 1: 287-291.
24. Lee JY, Duke RK, Tran VH, Hook JM, Duke CC (2006) Hyperforin and its analogues inhibit CYP3A4 enzyme activity. Phytochemistry 67: 2550-2560.
25. Verotta L, Sterner O, Appendino G, Bombardelli E, Pilati T (2006) The reaction of hyperforin with hydride reducing agents. Eur J Org Chem 2006. pp 5479-5484.
26. Rodríguez-Nieto S, González-Iriarte M, Carmona R, Muñoz-Chápuli R, Medina MA, et al. (2002) Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. Faseb J 16: 261-263.
27. Cárdenas C, Quesada AR, Medina MA (2006) Evaluation of the anti-angiogenic effect of aloe-emodin. Cell Mol Life Sci 63: 3083-3089.